H.R.277 — Regulations from the Executive in Need of Scrutiny Act of 2023

House Roll Call

H.R.277

Roll 257 • Congress 118, Session 1 • Jun 14, 2023 3:05 PM • Result: Failed

← Back to roll call list • View bill page • Clerk record • API source

BillH.R.277 — Regulations from the Executive in Need of Scrutiny Act of 2023
Vote questionOn Agreeing to the Amendment
Vote typeRecorded Vote
ResultFailed
TotalsYea 211 / Nay 223 / Present 0 / Not Voting 5
PartyYeaNayPresentNot Voting
R2111003
D021302
I0000

Research Brief

On Agreeing to the Amendment

Bill Analysis

Summary of HR 277 - Regulations from the Executive in Need of Scrutiny Act of 2023

HR 277, introduced in the 118th Congress, aims to enhance legislative oversight of executive branch regulations. The bill establishes a framework for Congress to review and potentially disapprove significant regulations proposed by federal agencies, thereby increasing accountability and transparency in the regulatory process.

Key Provisions:

  • The bill mandates that any major rule—defined as regulations with an economic impact exceeding $100 million or that significantly affect various sectors—must be submitted to Congress for review before taking effect.
  • Congress is granted a period of 60 days to review and disapprove these rules through a joint resolution. If Congress fails to act within this timeframe, the rule can be enacted.
  • The legislation also requires agencies to provide a detailed analysis of the economic impacts of proposed rules, ensuring that lawmakers have the necessary information to make informed decisions.

Funding and Authorities: HR 277 does not allocate specific funding but empowers Congress to exercise its authority over regulatory actions. It reinforces the Congressional Review Act (CRA) by streamlining the process for disapproving regulations.

Agencies Affected: The bill impacts all federal agencies that issue major rules, including but not limited to the Environmental Protection Agency (EPA), the Department of Labor (DOL), and the Food and Drug Administration (FDA).

Beneficiaries and Regulation: The primary beneficiaries of HR 277 are businesses and industries that may face regulatory burdens, as the bill aims to reduce the number of regulations that can be implemented without legislative oversight. Additionally, it seeks to protect consumers by ensuring that regulations are subject to thorough scrutiny.

Key Timelines: As of the latest action, HR 277 has been read a second time and placed on the Senate Legislative Calendar under General Orders, indicating it is awaiting further consideration. The timeline for potential enactment will depend on subsequent legislative actions and votes in both chambers of Congress.

View bill source • Clerk record • API record

Yea (211)

K
Kelly Armstrong

ND • R • Aye

D
Dan Bishop

NC • R • Aye

K
Ken Buck

CO • R • Aye

L
Larry Bucshon

IN • R • Aye

M
Michael Burgess

TX • R • Aye

K
Ken Calvert

CA • R • Aye

J
Jerry Carl

AL • R • Aye

L
Lori Chavez-DeRemer

OR • R • Aye

J
John Duarte

CA • R • Aye

J
Jeff Duncan

SC • R • Aye

A
A. Ferguson

GA • R • Aye

S
Scott Franklin

FL • R • Aye

M
Matt Gaetz

FL • R • Aye

M
Mike Gallagher

WI • R • Aye

M
Mike Garcia

CA • R • Aye

B
Bob Good

VA • R • Aye

K
Kay Granger

TX • R • Aye

G
Garret Graves

LA • R • Aye

M
Mark Green

TN • R • Aye

B
Bill Johnson

OH • R • Aye

D
Doug Lamborn

CO • R • Aye

J
Jake LaTurner

KS • R • Aye

D
Debbie Lesko

AZ • R • Aye

B
Blaine Luetkemeyer

MO • R • Aye

L
Lisa McClain

MI • R • Aye

M
Marcus Molinaro

NY • R • Aye

A
Alexander Mooney

WV • R • Aye

G
Greg Pence

IN • R • Aye

B
Bill Posey

FL • R • Aye

C
Cathy Rodgers

WA • R • Aye

M
Matthew Rosendale

MT • R • Aye

J
John Rutherford

FL • R • Aye

G
George Santos

NY • R • Aye

D
David Schweikert

AZ • R • Aye

P
Pete Sessions

TX • R • Aye

M
Michelle Steel

CA • R • Aye

C
Chris Stewart

UT • R • Aye

M
Michael Waltz

FL • R • Aye

B
Brad Wenstrup

OH • R • Aye

B
Brandon Williams

NY • R • Aye

Nay (223)

C
Colin Allred

TX • D • No

E
Earl Blumenauer

OR • D • No

J
Jamaal Bowman

NY • D • No

C
Cori Bush

MO • D • No

Y
Yadira Caraveo

CO • D • No

T
Tony Cárdenas

CA • D • No

M
Matt Cartwright

PA • D • No

G
Gerald Connolly

VA • D • No

J
Jason Crow

CO • D • No

A
Anthony D'Esposito

NY • R • No

L
Lloyd Doggett

TX • D • No

A
Anna Eshoo

CA • D • No

R
Ruben Gallego

AZ • D • No

J
John Garamendi

CA • D • No

J
Jenniffer González-Colón

PR • R • No

R
Raúl Grijalva

AZ • D • No

B
Brian Higgins

NY • D • No

J
Jeff Jackson

NC • D • No

S
Sheila Jackson Lee

TX • D • No

D
Daniel Kildee

MI • D • No

D
Derek Kilmer

WA • D • No

A
Ann Kuster

NH • D • No

B
Barbara Lee

CA • D • No

K
Kathy Manning

NC • D • No

L
Lucy McBath

GA • D • No

G
Grace Napolitano

CA • D • No

W
Wiley Nickel

NC • D • No

B
Bill Pascrell

NJ • D • No

D
Donald Payne

NJ • D • No

M
Mary Peltola

AK • D • No

D
Dean Phillips

MN • D • No

K
Katie Porter

CA • D • No

C
C. Ruppersberger

MD • D • No

G
Gregorio Sablan

MP • D • No

J
John Sarbanes

MD • D • No

A
Abigail Spanberger

VA • D • No

E
Eric Swalwell

CA • D • No

R
Rashida Tlaib

MI • D • No

D
David Trone

MD • D • No

N
Nydia Velázquez

NY • D • No

D
Debbie Wasserman Schultz

FL • D • No

J
Jennifer Wexton

VA • D • No

S
Susan Wild

PA • D • No

Not Voting (5)

P
Patrick McHenry

NC • R • Not Voting